Newborn Screening Collaborative Seeks Your Input
The Newborn Screening Collaborative (NBSC), founded in 2025, is aimed at improving newborn screening programs across the United States. This volunteer organization comprises patient advocates, public health experts, and healthcare professionals united under a common goal — to ensure that all newborns are screened for specific health conditions that can significantly impact their futures.
Purpose of the NBSC
The NBSC's primary mission is to provide guidance based on transparent and evidence-based reviews. By assessing various conditions, the collaborative aims to recommend which ailments should be included in routine newborn screenings. Every year, countless infants are born with conditions that go undetected until they develop into severe health issues. Therefore, early detection is crucial. The NBSC believes that through meticulous review and stakeholder participation, they can enhance health outcomes for newborns nationwide.
Call for Nominations
As part of its objectives, the NBSC is preparing for its inaugural official meeting this summer. In anticipation of this, they are encouraging organizations and individuals to suggest conditions they believe warrant a thorough review. This input is integral to the collaborative's evaluative process, ensuring that they consider various perspectives within the healthcare community.
Pre-Submission Guidelines
Currently, the NBSC is accepting pre-submissions for nominees through April 30, 2026. If you wish to contribute, you can request a pre-submission form by emailing
[email protected]. The information required at this stage includes:
- - The name of the condition(s)
- - A brief explanation of why this condition should be reviewed
- - A summary of the supporting data available
It is emphasized that only preliminary information is requested at this point. The full nomination process will be introduced in the future, which will allow for more comprehensive submissions.
Comprehensive Review Process
The NBSC will review the submitted conditions meticulously, leveraging data collected from various vital resources such as newborn screening results, natural history studies, and clinical trials. Their approach aims not just at adherence to guidelines but facilitating a deeper understanding of how each recommended condition behaves during the first stages of life, identified through screening efforts.
Oversight and Support
The NBSC operates under the auspices of the American College of Medical Genetics and Genomics (ACMG), ensuring that their procedures align with recognized medical standards. Moreover, it receives support from the ACMG Foundation for Genetic and Genomic Medicine (ACMGF), advocating for the utilization of genetic and genomic insights in screening practices.
Future Directions
This collaborative effort is poised to play a pivotal role in shaping future newborn screening policies. By pooling knowledge and resources from diverse medical backgrounds and linking them to actionable outcomes, the NBSC aspires to enhance the efficacy of newborn health screenings. This, in turn, would mean that healthcare providers across the United States would have access to better data-driven insights on conditions affecting newborns.
As more details regarding the first official meeting and subsequent processes become available, updates will be shared via the official NBSC website at
acmg.net/nbsc.aspx.
Your Opportunity to Make a Difference
The NBSC values your input and encourages everyone in the healthcare field, including researchers, physicians, and the general public, to take part in this essential initiative. Together, let’s work toward a healthier future for every newborn.